Emerald

UK-based healthtech company reimagining preventive care. Combining diagnostics, AI, and GP insights helps people take control of their health before symptoms appear. The platform’s AI engine analyses data from blood tests, wearables, and lifestyle inputs, identifying early warning signs and suggesting actionable steps —an integrated approach rarely found in existing NHS and private pathways.

Emerald has raised €1.7M across 2 funding rounds from 13 investors, most recently a Pre-Seed round in Jan 2026. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.